at Zacks.com (Tue, 4:40PM)
More on Medtronic (MDT) FQ3: net profit +5.7% to $988M; Sales breakdown: cardiac rhythm disease management -1% excluding currency fluctuations; spinal products -3%. Affirms 2013 guidance for EPS of $3.66-3.70 vs forecasts of $3.68 and revenue growth of 3-4% at constant currencies.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Jan 22, 2015)
at Nasdaq.com (Jan 20, 2015)
at Zacks.com (Jan 15, 2015)
at Zacks.com (Jan 14, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs